Quratis, Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
- Drug Discovery Technologies
Latest on Quratis, Inc.
As the COVID-19 vaccination rate continues to climb in South Korea, EyeGene, Inc. , like other vaccine developers, is facing difficulties in progressing recruitment for clinical trials with its own v
GSK Files Sotrovimab Emergency Use In Japan GlaxoSmithKline plc has submitted an application in Japan for an emergency use authorization (EUA) for its single-dose monoclonal antibody sotrovimab for
India’s Gennova Biopharmaceuticals Ltd tied up with Seattle-based HDT Bio Corp. in July 2020, soon after the latter announced in February that year that it was working on an mRNA COVID-19 vaccine.
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. InnoCare Licenses Greater China Rights